Phytosterols Synergize With Endotoxin to Augment Inflammation in Kupffer Cells but Alone Have Limited Direct Effect on Hepatocytes
- 11 December 2017
- journal article
- research article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 42 (1) , 37-48
Abstract
Introduction: Phytosterols are implicated in the development of parenteral nutrition–associated liver disease. A newly proposed mechanism for phytosterol‐mediated parenteral nutrition–associated liver disease is through phytosterol‐facilitated hepatic proinflammatory cytokine release following exposure to intestinally derived bacteria. Whether the proinflammatory effects are liver cell specific is not known. Aim: To determine if phytosterols cause inflammation in hepatocytes or Kupffer cells independently or require costimulation by lipopolysaccharide (LPS). Methods: In an in vivo study, neonatal piglets on parenteral nutrition for 11 days received an 8‐hour infusion of LPS. In the in vitro studies, neonatal piglet Kupffer cells and hepatocytes were treated with media, media + 1% soy oil, or media + 1% soy oil + 100µM phytosterols. After 24‐hour incubation, cells were treated with farnesoid X receptor (FXR) agonist obeticholic acid or liver X receptor (LXR) agonist GW3965 and challenged with LPS or interleukin 1β. Results: LPS administration in piglets led to transient increases in proinflammatory cytokines and suppression of the transporters bile salt export pump and ATP‐binding cassette transporter G5. In hepatocytes, phytosterols did not activate inflammation. Phytosterol treatment alone did not activate inflammation in Kupffer cells but, combined with LPS, synergistically increased interleukin 1β production. FXR and LXR agonists increased transporter expression in hepatocytes. GW3965 suppressed proinflammatory cytokine production in Kupffer cells, but obeticholic acid did not. Conclusions: LPS suppresses transporters that control bile acid and phytosterol clearance. Phytosterols alone do not cause inflammatory response. However, with costimulation by LPS, phytosterols synergistically maximize the inflammatory response in Kupffer cells.Keywords
This publication has 35 references indexed in Scilit:
- Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein–1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver diseaseMetabolism, 2012
- Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Activation of Liver X Receptors Attenuates Endotoxin-Induced Liver Injury in Mice with Nonalcoholic Fatty Liver DiseaseDigestive Diseases and Sciences, 2011
- Near-infrared spectroscopy measurement of abdominal tissue oxygenation is a useful indicator of intestinal blood flow and necrotizing enterocolitis in premature pigletsJournal of Pediatric Surgery, 2011
- The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate ImmunityThe Journal of Immunology, 2009
- Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β–induced apoptosis†Hepatology, 2009
- Lipid synthesis in macrophages during inflammation in vivo: Effect of agonists of peroxisome proliferator activated receptors α and γ and of retinoid X receptorsBiochemistry (Moscow), 2008
- Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndromeAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional processAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- The Farnesoid X-receptor Is an Essential Regulator of Cholesterol HomeostasisJournal of Biological Chemistry, 2003